Norwegian Cruise Line Holdings Ltd. (N1CL34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 20 Oct 2026
Key indicators
| Last close | BRL 79.12 |
|---|---|
| 52-week range | 72.00 – 131.04 |
| Return, 1 month / 3 months | +8.2% / −20.3% |
| Return, 1 year / 3 years | −39.1% / +9.0% |
| Trend | Below its 200-day average |
| RSI (14) | 58 |
| Volatility (1 year) | 54.7% |
| Worst drawdown (1 year) | -45.1% |
| Average daily value traded | 0.03M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Norwegian Cruise Line Holdings operates cruise lines that carry passengers on voyages to destinations around the world. Its brands offer ocean cruises with a range of dining, entertainment and onboard activities, serving leisure travellers and holidaymakers. The company is based in Miami, Florida, and its ships sail in regions including the Caribbean, the Mediterranean, Alaska and other coastal and island destinations. It also provides related onboard services and shore excursions for its guests.
Norwegian Cruise Line Holdings Ltd. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code N1CL34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Norwegian Cruise Line Holdings Ltd. (N1CL34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 79.12 on 20 October 2026.
Its price-based Market X-Ray is 20 out of 100 (a weak price profile), ranking 1,348 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.1% and over the last three months it fell 20.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 14 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.6% | ||
| From 52-week high | -39.6% | ||
| Momentum | 10 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.3% | ||
| 6-month return | -21.1% | ||
| 12-month return, skipping the last month | -43.7% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 54.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.1% | ||
| Liquidity | 34 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M BRL | ||
| Zero-volume days | 40.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.3% |
|---|---|
| 1 month | +8.2% |
| 3 months | −20.3% |
| 6 months | −21.1% |
| 1 year | −39.1% |
| 3 years | +9.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 80.93 / 98.35 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.03 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.